Larimar Therapeutics logo

Larimar Therapeutics share price today

(LRMR)

Larimar Therapeutics share price is $3.97 & ₹340.67 as on 7 Jan 2025, 2.30 'hrs' IST

$3.97

-0.21

(-5.02%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Larimar Therapeutics share price in Dollar and Rupees. Guide to invest in Larimar Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Larimar Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Larimar Therapeutics share price movements

  • Today's Low: $3.96
    Today's High: $4.22

    Day's Volatility :6.16%

  • 52 Weeks Low: $3.01
    52 Weeks High: $13.68

    52 Weeks Volatility :78.0%

Larimar Therapeutics Returns

PeriodLarimar Therapeutics IncIndex (Russel 2000)
3 Months
-41.04%
0.0%
6 Months
-52.8%
0.0%
1 Year
-8.13%
0.0%
3 Years
-54.37%
-19.8%

Larimar Therapeutics Key Statistics

in dollars & INR

Previous Close
$4.18
Open
$4.2
Today's High
$4.22
Today's Low
$3.96
Market Capitalization
$246.9M
Today's Volume
$671.8K
52 Week High
$13.68
52 Week Low
$3.01
Revenue TTM
$0.0
EBITDA
$-73.4M
Earnings Per Share (EPS)
$-1.15
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-44.5%

How to invest in Larimar Therapeutics from India?

It is very easy for Indian residents to invest directly in Larimar Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Larimar Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Larimar Therapeutics or LRMR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Larimar Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Larimar Therapeutics shares which would translate to 0.216 fractional shares of Larimar Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Larimar Therapeutics, in just a few clicks!

Returns in Larimar Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Larimar Therapeutics investment value today

Current value as on today

₹90,475

Returns

₹9,525

(-9.52%)

Returns from Larimar Therapeutics Stock

₹12,747 (-12.75%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Larimar Therapeutics

133%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Larimar Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 133% more investors are searching Larimar Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Larimar Therapeutics

  • Deerfield Management Co

    33.28%

  • RA Capital Management, LLC

    9.47%

  • HHG PLC

    8.72%

  • Goldman Sachs Group Inc

    6.66%

  • Blue Owl Capital Holdings LP

    6.53%

  • BlackRock Inc

    4.91%

Analyst Recommendation on Larimar Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Larimar Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Larimar Therapeutics

What analysts predicted

Upside of 414.06%

Current:

$3.97

Target:

$20.41

Insights on Larimar Therapeutics

  • Price Movement

    In the last 1 month, LRMR stock has moved down by -35.3%
  • LRMR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 34.4%
  • LRMR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 113.9%

Larimar Therapeutics Technicals Summary

Sell

Neutral

Buy

Larimar Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Larimar Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Larimar Therapeutics Inc
-38.17%
-52.8%
-8.13%
-54.37%
-66.02%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Larimar Therapeutics Inc
NA
NA
NA
-1.23
-0.44
-0.29
NA
3.11
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Larimar Therapeutics Inc
Buy
$246.9M
-66.02%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Larimar Therapeutics

larimar therapeutics, inc. (nasdaq:lrmr), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. the company’s lead compound, cti-1601, is currently being evaluated in a phase 1 clinical program as a potential treatment for friedreich’s ataxia, a rare and progressive genetic disease. larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. for more information, please visit: https://larimartx.com.
Organization
Larimar Therapeutics
Employees
42
CEO
Dr. Carole S. Ben-Maimon M.D.
Industry
Health Technology

Management People of Larimar Therapeutics

NameTitle
Dr. Carole S. Ben-Maimon M.D.
CEO, President & Director
Mr. Michael Celano CPA
Secretary & CFO
Dr. Gopi Shankar M.B.A., Ph.D.
Chief Development Officer
Mr. John Berman
Vice President of Finance & Administration
Ms. Jennifer Spokes Johansson
Vice President of Legal & Compliance
Dr. Russell G. Clayton Sr., D.O, D.O.
Chief Medical Officer
Mr. Francis Michael Conway CPA
VP & Controller

Important FAQs about investing in Larimar Therapeutics from India :

What is Larimar Therapeutics share price today?

Larimar Therapeutics share price today stands at $3.97, Open: $4.20 ; Previous Close: $4.18 ; High: $4.22 ; Low: $3.96 ; 52 Week High: $13.68 ; 52 Week Low: $3.01. The stock opens at $4.20, after a previous close of $4.18. The stock reached a daily high of $4.22 and a low of $3.96, with a 52-week high of $13.68 and a 52-week low of $3.01.

Can Indians buy Larimar Therapeutics shares?

Yes, Indians can invest in the Larimar Therapeutics (LRMR) from India.

With INDmoney, you can buy Larimar Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Larimar Therapeutics at zero transaction cost.

How can I buy Larimar Therapeutics shares from India?

It is very easy to buy Larimar Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Larimar Therapeutics be purchased?

Yes, you can buy fractional shares of Larimar Therapeutics with INDmoney app.

What are the documents required to start investing in Larimar Therapeutics stocks?

To start investing in Larimar Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Larimar Therapeutics

Today’s highest price of Larimar Therapeutics (LRMR) is $4.22.

Today’s lowest price of Larimar Therapeutics (LRMR) is $3.96.

What is today's market capitalisation of Larimar Therapeutics

Today's market capitalisation of Larimar Therapeutics LRMR is 246.9M

What is the 52 Week High and Low Range of Larimar Therapeutics

  • 52 Week High

    $13.68

  • 52 Week Low

    $3.01

What are the historical returns of Larimar Therapeutics?

  • 1 Month Returns

    -38.17%

  • 3 Months Returns

    -52.8%

  • 1 Year Returns

    -8.13%

  • 5 Years Returns

    -66.02%

Who is the Chief Executive Officer (CEO) of Larimar Therapeutics

Dr. Carole S. Ben-Maimon M.D. is the current Chief Executive Officer (CEO) of Larimar Therapeutics.